http://www.news.uzh.ch/en/allnews/focus/precisionmedicine.html http://www.news.uzh.ch/en/articles/news/2026/magazine-pediatric-oncology.html Today, many children with cancer can be treated successfully. A new Center of Competence in Research aims to make treatments even more targeted and effective. Read more in the UZH Magazin. Sun, 21 Jun 2026 22:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/magazine-pediatric-oncology.html UZH Communications 2026-06-21T22:00:00Z http://www.news.uzh.ch/en/articles/news/2026/g%C3%B6tz-preis-2026.html Raphael Morscher, of the University Children’s Hospital Zurich, received the award for his research examining the metabolism of cancer cells as a potential therapeutic approach for neuroblastoma. Mon, 25 May 2026 22:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/g%C3%B6tz-preis-2026.html UZH Kommunikation 2026-05-25T22:00:00Z http://www.news.uzh.ch/en/articles/media/2026/gene-editing-epilepsy.html Scientists used gene editing to fix faulty DNA directly in the brain cells of mice, which reduced fever-induced seizures and markedly improved survival rates in an animal model. Tue, 12 May 2026 22:00:00 GMT http://www.news.uzh.ch/en/articles/media/2026/gene-editing-epilepsy.html 2026-05-12T22:00:00Z http://www.news.uzh.ch/en/articles/media/2026/anti-nogo-a-therapy.html Scientists at UZH and Balgrist University Hospital reveal for the first time how the antibody therapy works: new nerve fibers were found to form functional connections once again. Mon, 11 May 2026 22:00:00 GMT http://www.news.uzh.ch/en/articles/media/2026/anti-nogo-a-therapy.html 2026-05-11T22:00:00Z http://www.news.uzh.ch/en/articles/news/2026/protein-synthesis.html Ataman Sendoel is researching how tumors are able to misuse protein production for their purposes. And he is looking for substances to prevent this. Tue, 28 Apr 2026 22:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/protein-synthesis.html Text: Adrian Ritter, translated by Michael Jackson 2026-04-28T22:00:00Z http://www.news.uzh.ch/en/articles/news/2026/microbiome-project.html New research from Zurich shows that the gut microbiome may have an impact on cancer immunotherapy, giving patients who did not initially respond to treatment a second chance. Thu, 09 Apr 2026 22:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/microbiome-project.html Marita Fuchs 2026-04-09T22:00:00Z http://www.news.uzh.ch/en/articles/news/2026/spin-offs-patents.html At UZH, basic research brings about innovative products and applications. Researchers at UZH filed several patents in 2025, and four new spin-offs were created. Sun, 22 Mar 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/spin-offs-patents.html Norbert Raabe and Carole Scheidegger 2026-03-22T23:00:00Z http://www.news.uzh.ch/en/articles/news/2026/antibiotics.html Oliver Zerbe is working on an active substance that attacks pathogenic bacteria in a novel way and eliminates them. Mon, 16 Feb 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/antibiotics.html Adrian Ritter 2026-02-16T23:00:00Z http://www.news.uzh.ch/en/articles/media/2026/Cancer-Heart-Attack.html Researchers have developed an AI-based risk prediction model that combines cancer-related and traditional cardiovascular factors. Thu, 29 Jan 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/media/2026/Cancer-Heart-Attack.html 2026-01-29T23:00:00Z http://www.news.uzh.ch/en/articles/media/2026/Sickle-Cell-Anemia.html Memantine, a cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data indicate that the active ingredient is well tolerated. Wed, 14 Jan 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/media/2026/Sickle-Cell-Anemia.html 2026-01-14T23:00:00Z http://www.news.uzh.ch/en/articles/news/2026/new-skin-for-burn-victims.html Researchers at UZH have been working on bio-engineered skin grafts for over 15 years, leading to the founding of spin-off Cutiss that produces living skin tissue from the patients’ own cells. Wed, 14 Jan 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/new-skin-for-burn-victims.html Marita Fuchs, Barbara Simpson 2026-01-14T23:00:00Z http://www.news.uzh.ch/en/articles/media/2026/multiple-sclerosis.html In addition to an infection with the Epstein-Barr virus, certain gene variants are also partly responsible for triggering MS. Together, these two risk factors lead to the autoimmune disease. Mon, 12 Jan 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/media/2026/multiple-sclerosis.html 2026-01-12T23:00:00Z http://www.news.uzh.ch/en/articles/news/2026/alzheimer-research.html How can we influence whether we develop Alzheimer’s disease? Researchers at UZH are examining the factors that trigger the onset of the disease – and those that shield us against it. Mon, 12 Jan 2026 23:00:00 GMT http://www.news.uzh.ch/en/articles/news/2026/alzheimer-research.html Text: Theo von Däniken/Translation: Philip Isler 2026-01-12T23:00:00Z http://www.news.uzh.ch/en/articles/news/2025/charles-weissmann.html The molecular biologist Charles Weissmann was one of the leading figures in his field, his research on the antiviral agent alpha interferon brought him worldwide recognition. He passed away last Friday in Zurich at the age of 94. Mon, 15 Dec 2025 23:00:00 GMT http://www.news.uzh.ch/en/articles/news/2025/charles-weissmann.html Roger Nickl; Translation: Barbara Simpson 2025-12-15T23:00:00Z http://www.news.uzh.ch/en/articles/media/2025/yeast-Candida-albicans.html The yeast Candida albicans can cause dangerous infections. UZH researchers have now discovered how the immune system prevents it from transforming to a pathogenic mode. Sun, 14 Dec 2025 23:00:00 GMT http://www.news.uzh.ch/en/articles/media/2025/yeast-Candida-albicans.html 2025-12-14T23:00:00Z http://www.news.uzh.ch/en/articles/news/2025/gretener-thuerlemann-prize-recipients.html For their research that has helped develop immunotherapies to combat various forms of cancer, Gordon Freeman and Arlene Sharpe are the laureates of the Gretener-Thürlemann Prize. Wed, 03 Dec 2025 23:00:00 GMT http://www.news.uzh.ch/en/articles/news/2025/gretener-thuerlemann-prize-recipients.html Adrian Ritter 2025-12-03T23:00:00Z http://www.news.uzh.ch/en/articles/media/2025/childhood-cancer-therapy.html Researchers from UZH and Kispi have developed a new approach to treat children with malignant tumors of the nervous system. Combined with a special diet, an approved drug slows tumor growth much more effectively. Sun, 19 Oct 2025 22:00:00 GMT http://www.news.uzh.ch/en/articles/media/2025/childhood-cancer-therapy.html 2025-10-19T22:00:00Z http://www.news.uzh.ch/en/articles/media/2025/AI-heart-attack.html A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than existing methods. This could enable doctors to guide more personalized treatment decisions for patients. Wed, 15 Oct 2025 22:00:00 GMT http://www.news.uzh.ch/en/articles/media/2025/AI-heart-attack.html 2025-10-15T22:00:00Z http://www.news.uzh.ch/en/articles/news/2025/checkpoint-inhibitor2.html Die Immun-Checkpoint-Inhibitoren sind aus der Krebstherapie bekannt. UZH-Forschende haben nun eine neue, wichtige Funktion dieser Inhibitoren identifiziert: Sie beschleunigen die Heilung von Gewebe. Dies könnte bei der Behandlung von Fibrosen und chronischen Wunden helfen. Tue, 14 Oct 2025 22:00:00 GMT http://www.news.uzh.ch/en/articles/news/2025/checkpoint-inhibitor2.html 2025-10-14T22:00:00Z http://www.news.uzh.ch/en/articles/media/2025/checkpoint-inhibitor.html UZH researchers have identified a new, important function of immune checkpoint inhibitors: promotion of tissue healing. This finding could help treat fibrosis and chronic wounds. Tue, 14 Oct 2025 22:00:00 GMT http://www.news.uzh.ch/en/articles/media/2025/checkpoint-inhibitor.html 2025-10-14T22:00:00Z